-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that Nurix Therapeutics (NRIX.US) continued its previous post-market decline before Wednesday after announcing that its partner SNY.US (SNY.US) decided to stop an experimental inflammatory disease treatment study. At press time, Nurix was down 32.96% to $17.31.

Zhitongcaijing·11/04/2026 13:33:37
Listen to the news
The Zhitong Finance App learned that Nurix Therapeutics (NRIX.US) continued its previous post-market decline before Wednesday after announcing that its partner SNY.US (SNY.US) decided to stop an experimental inflammatory disease treatment study. At press time, Nurix was down 32.96% to $17.31.